A triple growth factor strategy for optimizing bone augmentation in mice.

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Oral and Maxillofacial Surgery

Background:

• Dental implantology increasingly relies on bone augmentation techniques.
• Effective strategies are needed to enhance bone regeneration prior to implant placement.

Purpose of the Study:

• To evaluate a novel bone augmentation strategy using a combination of three key growth factors: bone morphogenetic protein-2 (BMP-2), insulin-like growth factor 1 (IGF-1), and vascular endothelial growth factor (VEGF).
• To assess the impact of these growth factors, delivered via collagen scaffolds, on hard tissue formation in a murine calvarial model.

Main Methods:

• Collagen scaffolds were fabricated with varying combinations of BMP-2, IGF-1, and VEGF.
• Scaffolds were implanted into the calvarias of C57BL/6JJcl mice.
• Hard tissue formation was analyzed using histological, tomographic, and biochemical methods at 10 and 28 days.

Main Results:

• The combination of BMP-2 and IGF-1 significantly increased hard tissue volume compared to BMP-2 alone.
• The group receiving BMP-2, IGF-1, and VEGF (BIV) demonstrated the greatest hard tissue formation.
• VEGF and CD31 levels were elevated in the BIV group at 10 days, but no correlation with M2 macrophage quantity was observed.

Conclusions:

• The simultaneous delivery of BMP-2, IGF-1, and VEGF via collagen scaffolds is a highly effective strategy for bone augmentation.
• This multi-growth factor approach shows promise for improving outcomes in dental implant procedures requiring bone regeneration.